annual accounts payable:
$258.69M+$115.12M(+80.18%)Summary
- As of today (September 18, 2025), AMRX annual accounts payable is $258.69 million, with the most recent change of +$115.12 million (+80.18%) on December 31, 2024.
- During the last 3 years, AMRX annual accounts payable has risen by +$127.61 million (+97.35%).
- AMRX annual accounts payable is now at all-time high.
Performance
AMRX Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$205.81M+$13.28M(+6.90%)Summary
- As of today (September 18, 2025), AMRX quarterly accounts payable is $205.81 million, with the most recent change of +$13.28 million (+6.90%) on June 30, 2025.
- Over the past year, AMRX quarterly accounts payable has increased by +$6.23 million (+3.12%).
- AMRX quarterly accounts payable is now -66.46% below its all-time high of $613.62 million, reached on September 30, 2020.
Performance
AMRX quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
AMRX Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +80.2% | +3.1% |
| 3 y3 years | +97.3% | -63.4% |
| 5 y5 years | +151.1% | -65.7% |
AMRX Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +97.3% | -63.4% | +50.3% |
| 5 y | 5-year | at high | +151.1% | -66.5% | +50.3% |
| alltime | all time | at high | >+9999.0% | -66.5% | >+9999.0% |
AMRX Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $205.81M(+6.9%) |
| Mar 2025 | - | $192.53M(-25.6%) |
| Dec 2024 | $258.69M(+80.2%) | $258.69M(+10.1%) |
| Sep 2024 | - | $235.00M(+17.7%) |
| Jun 2024 | - | $199.58M(+13.8%) |
| Mar 2024 | - | $175.32M(+22.1%) |
| Dec 2023 | $143.57M(-13.5%) | $143.57M(-19.1%) |
| Sep 2023 | - | $177.40M(+27.1%) |
| Jun 2023 | - | $139.53M(+1.9%) |
| Mar 2023 | - | $136.92M(-17.5%) |
| Dec 2022 | $165.98M(+26.6%) | $165.98M(-68.8%) |
| Sep 2022 | - | $531.46M(-5.4%) |
| Jun 2022 | - | $561.69M(+4.1%) |
| Mar 2022 | - | $539.73M(-7.5%) |
| Dec 2021 | $131.08M(-14.4%) | $583.35M(-1.0%) |
| Sep 2021 | - | $589.41M(-1.1%) |
| Jun 2021 | - | $596.23M(+3.8%) |
| Mar 2021 | - | $574.32M(-6.1%) |
| Dec 2020 | $153.14M(+48.6%) | $611.66M(-0.3%) |
| Sep 2020 | - | $613.62M(+2.4%) |
| Jun 2020 | - | $599.49M(-1.2%) |
| Mar 2020 | - | $606.92M(+489.1%) |
| Dec 2019 | $103.02M(-10.3%) | $103.02M(-79.2%) |
| Sep 2019 | - | $495.86M(-1.8%) |
| Jun 2019 | - | $505.14M(-9.6%) |
| Mar 2019 | - | $558.75M(+386.5%) |
| Dec 2018 | $114.85M(+64.0%) | $114.85M(-7.8%) |
| Sep 2018 | - | $124.54M(-26.3%) |
| Jun 2018 | - | $169.05M(>+9900.0%) |
| Mar 2018 | - | $0.00(-100.0%) |
| Dec 2017 | $70.01M(+18.8%) | $70.01M(+18.8%) |
| Dec 2016 | $58.95M(+4.7%) | - |
| Dec 2016 | - | $58.95M(-4.7%) |
| Sep 2016 | - | $61.88M(+22.5%) |
| Jun 2016 | - | $50.52M(-0.4%) |
| Mar 2016 | - | $50.72M(-9.9%) |
| Dec 2015 | $56.33M(+76.1%) | $56.33M(+51.1%) |
| Sep 2015 | - | $37.27M(+24.8%) |
| Jun 2015 | - | $29.87M(-39.5%) |
| Mar 2015 | - | $49.34M(+54.3%) |
| Dec 2014 | $31.98M(+19.2%) | $31.98M(-4.4%) |
| Sep 2014 | - | $33.45M(-8.6%) |
| Jun 2014 | - | $36.61M(+32.4%) |
| Mar 2014 | - | $27.65M(+3.1%) |
| Dec 2013 | $26.82M(-35.1%) | $26.82M(+3.5%) |
| Sep 2013 | - | $25.93M(-16.5%) |
| Jun 2013 | - | $31.06M(+1.5%) |
| Mar 2013 | - | $30.59M(-26.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $41.34M(+80.1%) | $41.34M(+45.9%) |
| Sep 2012 | - | $28.33M(+19.9%) |
| Jun 2012 | - | $23.64M(+27.3%) |
| Mar 2012 | - | $18.57M(-19.1%) |
| Dec 2011 | $22.95M(+22.0%) | $22.95M(+32.6%) |
| Sep 2011 | - | $17.31M(-6.4%) |
| Jun 2011 | - | $18.48M(+15.4%) |
| Mar 2011 | - | $16.01M(-14.9%) |
| Dec 2010 | $18.81M(-19.2%) | $18.81M(-1.8%) |
| Sep 2010 | - | $19.16M(-5.6%) |
| Jun 2010 | - | $20.29M(-39.0%) |
| Mar 2010 | - | $33.25M(+42.7%) |
| Dec 2009 | $23.30M(+82.0%) | $23.30M(+75.9%) |
| Sep 2009 | - | $13.24M(-6.6%) |
| Jun 2009 | - | $14.18M(+20.2%) |
| Mar 2009 | - | $11.79M(-7.8%) |
| Dec 2008 | $12.80M(-24.3%) | $12.80M(-15.4%) |
| Sep 2008 | - | $15.12M(-15.8%) |
| Jun 2008 | - | $17.95M(+6.2%) |
| Dec 2007 | $16.90M(+16.1%) | $16.90M(+16.1%) |
| Dec 2006 | $14.55M(+15.1%) | $14.55M(+15.1%) |
| Dec 2005 | $12.64M(-44.5%) | - |
| Sep 2004 | - | $12.64M(-43.3%) |
| Jun 2004 | - | $22.31M(-33.6%) |
| Mar 2004 | - | $33.59M(+47.4%) |
| Dec 2003 | $22.78M(+202.6%) | $22.78M(+46.4%) |
| Sep 2003 | - | $15.56M(+49.9%) |
| Jun 2003 | - | $10.38M(+7.1%) |
| Mar 2003 | - | $9.69M(+28.7%) |
| Dec 2002 | $7.53M(+88.4%) | $7.53M(+84.9%) |
| Sep 2002 | - | $4.07M(-5.4%) |
| Jun 2002 | - | $4.30M(-24.8%) |
| Mar 2002 | - | $5.72M(+43.2%) |
| Dec 2001 | $4.00M(+75.6%) | $4.00M(+16.5%) |
| Sep 2001 | - | $3.43M(+208.1%) |
| Jun 2001 | - | $1.11M(-16.7%) |
| Mar 2001 | - | $1.34M(-41.3%) |
| Dec 2000 | $2.28M(-4.8%) | $2.28M(-28.7%) |
| Sep 2000 | - | $3.19M(-23.2%) |
| Jun 2000 | - | $4.16M(+15.3%) |
| Mar 2000 | - | $3.61M(+50.9%) |
| Dec 1999 | $2.39M(+157.8%) | $2.39M(+52.4%) |
| Sep 1999 | - | $1.57M(+36.5%) |
| Jun 1999 | - | $1.15M(+59.1%) |
| Mar 1999 | - | $722.00K(-22.1%) |
| Dec 1998 | $927.00K | $927.00K(+79.0%) |
| Sep 1998 | - | $518.00K(-17.1%) |
| Jun 1998 | - | $625.00K(-15.4%) |
| Mar 1998 | - | $739.00K |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual accounts payable?
- What is the all time high annual accounts payable for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual accounts payable year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly accounts payable?
- What is the all time high quarterly accounts payable for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly accounts payable year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual accounts payable?
The current annual accounts payable of AMRX is $258.69M
What is the all time high annual accounts payable for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual accounts payable is $258.69M
What is Amneal Pharmaceuticals, Inc. annual accounts payable year-on-year change?
Over the past year, AMRX annual accounts payable has changed by +$115.12M (+80.18%)
What is Amneal Pharmaceuticals, Inc. quarterly accounts payable?
The current quarterly accounts payable of AMRX is $205.81M
What is the all time high quarterly accounts payable for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly accounts payable is $613.62M
What is Amneal Pharmaceuticals, Inc. quarterly accounts payable year-on-year change?
Over the past year, AMRX quarterly accounts payable has changed by +$6.23M (+3.12%)